By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1150 Bayhill Drive
Suite 203
San Bruno  California  94066  U.S.A.
Phone: 650-472-0632 Fax: 650-952-1827



Company News
Numerate And Takeda (TKPYY) Enter Agreement To Generate Novel Clinical Candidates Using AI-Driven Drug Discovery 6/12/2017 9:42:25 AM
Backed By New Investors Such As Lilly Ventures, Bay Area's Numerate Secures $8 Million 6/24/2014 6:11:07 AM
Numerate’s Drug Design Platform Scales to 10,000+ Cores Using Spot Instances 7/10/2012 10:16:21 AM
Numerate Announces Integration With Google Inc. Compute Engine 6/29/2012 9:20:06 AM
Numerate Forms Drug Discovery Collaboration with Merck & Co., Inc. (MRK) to Utilize Numerate’s In Silico Drug Design Technology 3/14/2012 8:36:14 AM
Numerate and Boehringer Ingelheim (Canada) Ltd. Form Research Collaboration Based on in silico Drug Design Technology 12/6/2011 7:23:35 AM
Numerate Appoints David Jobes, Ph.D., Senior Vice President of Business and Corporate Development 4/20/2011 6:56:26 AM
Numerate Awarded U.S. Department of Defense Contract to Extend Drug Design Platform 9/9/2010 12:11:21 PM
Congresswoman Speier to Join Numerate in Announcing U.S. Department of Defense Contract for Speeding Design of Biowarfare Countermeasures 9/7/2010 10:57:30 AM
Numerate and Intellikine, Inc. Conclude Research Collaboration to Discover Selective Inhibitors Against PI3 Kinase Alpha 8/11/2010 9:03:33 AM